Literature DB >> 6127357

Major tranquillisers used as antidepressants. A review.

M M Robertson, M R Trimble.   

Abstract

The use of major tranquillisers as antidepressants is reviewed and 34 double-blind trials evaluating this were found. Results suggest that some neuroleptics have antidepressant properties, although most studies have been conducted on mixed anxiety-depressive states. Advantages over the tricyclic antidepressants are the early onset of action and relative lack of side-effects. Post psychotic depression following major tranquilliser therapy is considered, and it is concluded that it is likely to be part of the underlying illness and not a drug-induced effect. It is suggested that further work with major tranquillisers in depression may be of value in exploring the mechanism of action of antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127357     DOI: 10.1016/0165-0327(82)90002-7

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?

Authors:  Carole Lavigne; Jocelyn Yelle; Gilles Sauve; Alain R Thierry
Journal:  AAPS PharmSci       Date:  2002

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  The Care of Patients With Complex Mood Disorders.

Authors:  Zachary A Cordner; Dean F MacKinnon; J Raymond DePaulo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 4.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

5.  The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

Authors:  S Kutcher; G Papatheodorou; S Reiter; D Gardner
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

Review 6.  Severe depression: is there a best approach?

Authors:  S B Sonawalla; M Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  The effect of amitriptyline treatment on the growth hormone response to apomorphine.

Authors:  P J Cowen; L E Braddock; B Gosden
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Olanzapine and fluoxetine combination in severe or resistant depression.

Authors:  R M Haridas; S R Parkar; Ram Ghulam; Gautam Amin; K G Thombre; A Srivastava; N Bhuvaneshwari; S Telang; Monika Obrah; Nandkishore Toraskar; R K Jalali; Kiran V Marthak
Journal:  Indian J Psychiatry       Date:  2003-10       Impact factor: 1.759

Review 9.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.

Authors:  B Costall; R J Naylor
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.